OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Clinical Laboratory Sciences is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Data analytics for error detection in clinical laboratories	69
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease	62
The dual roles of microorganisms in inflammatory diseases: initiators and regulators	55
Aptamer-based biosensing strategies for influenza virus detection: a systematic and critical review of electrochemical and optical platforms	52
The anion gap as a predictive tool for morbidity and mortality	52
Deep learning algorithms and Raman spectroscopy in the clinical laboratory setting	39
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review	38
Machine learning-based error detection in the clinical laboratory: a critical review	35
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application	34
Single cell mechanodeformation signatures as early biomarkers for hematological malignancies	33
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications	30
Transthyretin mutagenesis: impact on amyloidogenesis and disease	28
Clinical utility of human epididymis protein 4	27
Comparison of liquid biopsy-based technologies for cancer screening	26
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology	26
Beyond newborn screening: the role of reverse cascade testing in familial disease detection	24
Indirect methods for the verification of reference intervals in laboratory medicine	23
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation	23
Cardiovascular disease lipids and lipoproteins biomarker standardization	23
Mid-regional pro-atrial natriuretic peptide in managing cardiovascular and cerebrovascular diseases	22
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker	22
One health and laboratory medicine: challenges and perspectives for antimicrobial resistance, emerging infections, and food/water security	21
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration	21